Evaluating Feasibility of the YATAC Programme
Launched by DEFACTUM, CENTRAL DENMARK REGION · Jan 29, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The YATAC Programme is a new initiative aimed at helping young adults aged 18 to 39 who are recovering from cancer. The goal of this program is to provide support in various areas that are important for young adults as they transition back to everyday life after treatment. This includes setting personal goals, managing daily activities, coping with emotional challenges, and navigating education and work. The program was created based on feedback from young adults, their families, and healthcare professionals, ensuring it meets their specific needs.
Currently, the program is looking for young adults living in Copenhagen who have recently completed cancer treatment and feel they need support. Participants will take part in a study to see how helpful and relevant the program is for them. If you or someone you know fits the criteria, this could be a valuable opportunity to receive tailored support while also contributing to important research that aims to improve the lives of young adult cancer survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Included participants will be between 18-39 years old with any cancer diagnosis,
- • Undergoing or having undergone curative intended cancer treatment
- • Reporting a rehabilitation need
- • Speaking and understanding the Danish language
- • Living in the Municipality of Copenhagen
- Exclusion Criteria:
- • Young people aged 18-39 who were diagnosed with cancer before the age of 18.
About Defactum, Central Denmark Region
Defactum, situated in the Central Denmark Region, is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a strong focus on collaboration and scientific rigor, Defactum facilitates a range of clinical studies aimed at evaluating new therapeutic interventions and improving patient outcomes. Leveraging a network of experienced professionals and state-of-the-art facilities, Defactum is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives. Through its efforts, Defactum strives to contribute to the body of medical knowledge and enhance the quality of care in the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen N, , Denmark
Copenhagen, København N, Denmark
Copenhagen, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported